Abstract:Acute sleep deprivation has been shown to affect cerebrospinal fluid and plasma concentrations of biomarkers associated with neurodegeneration, though the mechanistic underpinnings remain unknown. This study compared individuals who, for one night, were either subject to total sleep deprivation or free sleep, (i) examining plasma concentrations of neurodegeneration biomarkers the morning after sleep deprivation or free sleep and (ii) determining how overnight changes in biomarkers plasma concentrations correlate with indices of meningeal lymphatic and glymphatic clearance functions. Plasma concentrations of amyloid-β 40 and 42, phosphorylated tau peptide 181, glial fibrillary acid protein and neurofilament light were measured longitudinally in subjects who from Day 1 to Day 2 either underwent total sleep deprivation (n = 7) or were allowed free sleep (n = 21). The magnetic resonance imaging contrast agent gadobutrol was injected intrathecally, serving as a cerebrospinal fluid tracer. Population pharmacokinetic model parameters of gadobutrol cerebrospinal fluid-to-blood clearance were utilized as a proxy of meningeal lymphatic clearance capacity and intrathecal contrast-enhanced magnetic resonance imaging as a proxy of glymphatic function. After one night of acute sleep deprivation, the plasma concentrations of amyloid-β 40 and 42 were reduced, but not the ratio, and concentrations of the other biomarkers were unchanged. The overnight change in amyloid-β 40 and 42 plasma concentrations in the sleep group correlated significantly with indices of meningeal lymphatic clearance capacity, while this was not seen for the other neurodegeneration biomarkers. However, overnight change in plasma concentrations of amyloid-β 40 and 42 did not correlate with the glymphatic marker. On the other hand, the overnight change in plasma concentration of phosphorylated tau peptide 181 correlated significantly with the marker of glymphatic function in the sleep deprivation group but not in the sleep group. The present data add to the evidence of the role of sleep and sleep deprivation on plasma neurodegeneration concentrations; however, the various neurodegeneration biomarkers respond differently with different mechanisms behind sleep-induced alterations in amyloid-β and tau plasma concentrations. Clearance capacity of meningeal lymphatics seems more important for sleep-induced changes in amyloid-β 40 and 42 plasma concentrations, while glymphatic function seems most important for change in plasma concentration of phosphorylated tau peptide 181 during sleep deprivation. Altogether, the present data highlight diverse mechanisms behind sleep-induced effects on concentrations of plasma neurodegeneration biomarkers.

Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.

Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers

0224 Sleep Deprivation and Recovery Sleep Impact Serum Biomarkers of Alzheimer's Disease in Retired Adults

Lateralized brunt of sleep deprivation on white matter injury in a rat model of Alzheimer's disease

Sleep Disturbance is Associated With Higher Plasma Aβ Levels in Cognitively Normal Adults—A Population-Based Cross-Sectional Study

Plasma amyloid‐β dynamics are regulated by the sleep‐wake cycle: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers

Plasma amyloid‐β dynamics are regulated by the sleep‐wake cycle

Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics

Sleep Disturbance is Associated with Mild Cognitive Impairment: a Community Population-Based Cross-Sectional Study

Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation

Interactions between sleep disturbances and Alzheimer's disease on brain function: a preliminary study combining the static and dynamic functional MRI.

The Association of Subjective Sleep Characteristics and Plasma Biomarkers of Alzheimer's Disease Pathology in Older Cognitively Unimpaired Adults with Higher Amyloid-Β Burden.

Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles

Plasma Aβ Level Alterations after Sleep Deprivation Correspond to Brain Structural Remodeling in Medical Night Shift Workers

Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta

β-Amyloid accumulation in the human brain after one night of sleep deprivation

1008 Daytime Sleepiness Is Associated with Increased Cerebrospinal Fluid Tau Proteins in Alzheimer’s Disease

Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning

Resting-state Functional Connectivity Changes in Older Adults with Sleep Disturbance and the Role of Amyloid Burden

Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease

P3‐186: THE DEPOLARIZATION AND INTERNALIZATION OF AQUAPORIN‐4 INDUCED BY SLEEP DEPRIVATION COULD INFLUENCE AMYLOID‐BETA CLEARANCE